Medicare Enrolled
Dr. Josebelo Chong, MD
Optician · Stockton, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chong?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chong
Dr. Josebelo Chong is an optician specialist in Stockton, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chong performed 2,222 Medicare services across 1,244 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chong received a total of $6,957 from 36 pharmaceutical and/or device companies across 353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chong is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 34% volume in CA
$6,957 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,222
Medicare services
Top 34% in CA for optician
1,244
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~117 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
719 | $167 | $450 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
555 | $64 | $110 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
256 | $95 | $170 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
249 | $65 | $120 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
117 | $141 | $300 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
44 | $30 | $100 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
44 | $43 | $95 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
43 | $45 | $105 |
| Insertion of non-tunneled central venous catheter A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin. |
40 | $66 | $370 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
25 | $11 | $50 |
| Bronchoscopy A diagnostic exam of the lung airways using an endoscope to visually inspect the inside of the lungs and airways. |
23 | $104 | $448 |
| Emergent tracheostomy An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope. |
22 | $110 | $215 |
| Arterial line insertion A tube is inserted into an artery through the skin to allow for blood sampling or infusion. |
20 | $35 | $120 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
20 | $85 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $132 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $101 | $170 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
12 | $92 | $165 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.8% high complexity
1.1% medium
97.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,957
Total received (2018-2024)
Avg $994/year across 7 years
Top 19% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
353
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,657 (95.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$300 (4.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,578
2023
$1,279
2022
$877
2021
$683
2020
$799
2019
$780
2018
$961
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$290
United Therapeutics Corporation
$279
AstraZeneca Pharmaceuticals LP
$260
GlaxoSmithKline, LLC.
$137
GENZYME CORPORATION
$132
Mylan Specialty L.P.
$94
ABBVIE INC.
$73
Amgen Inc.
$69
Insmed, Inc.
$59
Merck Sharp & Dohme LLC
$42
Regeneron Healthcare Solutions, Inc.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$33
Baxter Healthcare
$26
Pulmonx Corporation
$24
Paratek Pharmaceuticals, Inc.
$20
Top 3 companies account for 52.5% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,395
AstraZeneca Pharmaceuticals LP
$1,128
GlaxoSmithKline, LLC.
$773
United Therapeutics Corporation
$642
Insmed, Inc.
$430
Mylan Specialty L.P.
$339
GENZYME CORPORATION
$299
ABBVIE INC.
$261
Amgen Inc.
$205
Electromed, Inc.
$152
AbbVie Inc.
$121
Novartis Pharmaceuticals Corporation
$101
Regeneron Healthcare Solutions, Inc.
$100
Advanced Respiratory, Inc
$97
MAYNE PHARMA INC.
$92
Actelion Pharmaceuticals US, Inc.
$85
Takeda Pharmaceuticals U.S.A., Inc.
$80
EKOS Corporation
$75
Paratek Pharmaceuticals, Inc.
$62
Grifols USA, LLC
$52
Genentech USA, Inc.
$44
Merck Sharp & Dohme LLC
$42
Allergan, Inc.
$42
Janssen Pharmaceuticals, Inc
$41
Gilead Sciences, Inc.
$40
IDORSIA PHARMACEUTICALS US INC
$37
Astellas Pharma US Inc
$30
Merck Sharp & Dohme Corporation
$29
ADVANCED RESPIRATORY, INC
$26
Baxter Healthcare
$26
Pulmonx Corporation
$24
Ambu Inc.
$19
Melinta Therapeutics, LLC
$18
Mallinckrodt Hospital Products Inc.
$18
Circassia Pharmaceuticals Inc
$17
E.R. Squibb & Sons, L.L.C.
$16
Top 3 companies account for 47.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · ANORO · AREXVY · AVYCAZ · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · CHARTIS CATHETER · DALVANCE · DORYX · DUPIXENT · EKOSONIC · ELIQUIS · ENTRESTO · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Vest System Model 105 Home Care · Life 2000 Ventilation System · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENITRAM · Perforomist · Prolastin-C Liquid · QUVIVIQ · RECARBRIO · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Vabomere · WINREVAIR · XARELTO · Xolair · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
77
Per 100K population
9.8
County median income
$88,531
Nearest hospital
ST JOSEPH'S MEDICAL CENTER OF STOCKTON
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chong is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chong experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Chong performed 719 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chong receive payments from pharmaceutical companies?
Yes. Dr. Chong received a total of $6,957 from 36 companies across 353 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chong's costs compare to other opticians in Stockton?
Dr. Chong's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Stockton
Browse opticians in Stockton ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology